Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI

Lung cancer has the highest incidence and mortality rate worldwide among all malignancy-associated mortalities, of which non-small cell lung cancer accounts for 80% of all cases. Resistance against epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) develops following 8–12 months...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Cheong, Hio Teng, Xu, Fei, Choy, Chi Tung, Hui, Connie Wun Chun, Mok, Tony Shu Kam, Wong, Chi Hang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2018
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772989/
https://ncbi.nlm.nih.gov/pubmed/29422965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7377
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia